Jeevan Diagnost Pharmaceuticals Private Limited
About Jeevan Diagnost Pharmaceuticals Private Limited
Data last updated:
Jeevan Diagnost Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 02 April 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2014PTC267483. Its GSTIN is 07AADCJ3138Q1Z6 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Omhari Yadav and Awadhesh Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 29 South Anarkali Delhi, Delhi, India – 110051.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.87 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net profit of ₹13,084 (net margin 0.9%) and EBITDA of ₹13,084 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jeevan Diagnost Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 29 South Anarkali Delhi, Delhi, India – 110051
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Jeevan Diagnost Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jeevan Diagnost Pharmaceuticals Private Limited
FY 2025 filings availableJeevan Diagnost Pharmaceuticals Private Limited reported revenue of ₹13.87 Lakh (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13,084 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,084 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jeevan Diagnost Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jeevan Diagnost Pharmaceuticals Private Limited
Jeevan Diagnost Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Omhari Yadav | Director | 02 Apr 2014 | 12 Years 6 Months | Current |
| Awadhesh Singh | Director | 02 Apr 2014 | 12 Years 6 Months | Current |
| Nisha Yadav | Director | 02 Apr 2014 | 12 Years 6 Months | Current |
Peer comparison
Jeevan Diagnost Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biovams Pharmaceuticals Private Limited | ₹13.9 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India | |||
| Decorum Pharmaceuticals Private Limited | ₹13.87 Lakh (FY 2024) | -5.0% | Patna, Bihar, India | |||
| Jeevan Diagnost Pharmaceuticals Private Limitedthis company | ₹13.87 Lakh (FY 2025) | ₹13,084 | 0.9% | -51.0% | Delhi, India | |
| Samank Pharmaceuticals Private Limited | ₹13.75 Lakh (FY 2023) | 5.0% | Thane, Maharashtra, India |
To see the full peer comparison of Jeevan Diagnost Pharmaceuticals Private Limited, buy the company report.
Auditor
Jeevan Diagnost Pharmaceuticals Private Limited is audited by Pradeep Chand Gupta & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pradeep Chand Gupta & Co. | FY 2017 | 085479 |
Shareholding
The shareholding of Jeevan Diagnost Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jeevan Diagnost Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jeevan Diagnost Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jeevan Diagnost Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jeevan Diagnost Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCJ3138Q1Z6 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jeevan Diagnost Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jeevan Diagnost Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Awadhesh Singh was appointed as Director on 02 Apr 2014.
Frequently asked questions
Jeevan Diagnost Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 02 April 2014 (12+ years old) and is registered under CIN U74999DL2014PTC267483.
Jeevan Diagnost Pharmaceuticals has 3 current directors:
- Omhari Yadav - Director
- Awadhesh Singh - Director
- Nisha Yadav - Director
The latest financial statements of Jeevan Diagnost Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jeevan Diagnost Pharmaceuticals is 07AADCJ3138Q1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Jeevan Diagnost Pharmaceuticals is U74999DL2014PTC267483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jeevan Diagnost Pharmaceuticals was incorporated on 02 April 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jeevan Diagnost Pharmaceuticals by revenue are Biovams Pharmaceuticals Private Limited, Decorum Pharmaceuticals Private Limited, Samank Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Awadhesh Singh was appointed as Director on 02 Apr 2014. Nisha Yadav was appointed as Director on 02 Apr 2014. Omhari Yadav was appointed as Director on 02 Apr 2014.
The registered office of Jeevan Diagnost Pharmaceuticals is at S – 29 South Anarkali Delhi, Delhi, India – 110051.
Jeevan Diagnost Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Jeevan Diagnost Pharmaceuticals is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.